Biodesix year-end earnings beat analyst expectations as COVID testing revenue rises

Outlet: Daily Camera

Daily Camera: Biodesix and its partner Bio-Rad Laboratories Inc. (NYSE: BIO) worked to develop active-infection and antigen tests earlier in the pandemic, and the company currently counts Colorado State University, Purdue University and the Chicago Public Schools system among its largest customers for ongoing testing.